Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D75GUN
|
|||
| Drug Name |
PLX-200
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | CLN3 Batten disease [ICD-11: 5C56] | Phase 3 | [1] | |
| Company |
Polaryx Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04637282) A Randomized. Multicenter, Double-Blind, Placebo-Controlled Safety, Tolerability, and Efficacy Study of PLX-200 in Participants With Mild-to-Moderate Juvenile Neuronal Ceroid Lipofuscinosis (CLN3) Disease. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.